Gates Foundation Strategic Investment Fund Logo
Share this page:

Press Release: Intestinal Inflammation in Infants Dramatically Reduced with Bifidobacterium infantis

University of California, Davis Study Shows up to 98% Reduction of Intestinal Inflammation Markers Linked to Colic, Eczema, Asthma and Diabetes

DAVIS, Calif., Sept. 10, 2019 /PRNewswire/ — Findings from a new study published today in Pediatric Research show that feeding activated Bifidobacterium infantis (B. infantis) EVC001 to breastfed infants reduced markers of chronic intestinal inflammation by up to 98 percent during the first two months of life, which is a critical period of immune system development. The study was led by researchers from the University of California, Davis and was funded by Evolve BioSystems, a company leading the field of infant gut microbiome research.

Read full text here.